ID PARL_HUMAN Reviewed; 379 AA. AC Q9H300; Q96CQ4; Q9BTJ6; Q9P1E3; DT 12-APR-2005, integrated into UniProtKB/Swiss-Prot. DT 03-APR-2007, sequence version 2. DT 27-MAR-2024, entry version 177. DE RecName: Full=Presenilin-associated rhomboid-like protein, mitochondrial; DE EC=3.4.21.105 {ECO:0000269|PubMed:22354088}; DE AltName: Full=Mitochondrial intramembrane cleaving protease PARL; DE Contains: DE RecName: Full=P-beta; DE Short=Pbeta; DE Flags: Precursor; GN Name=PARL; Synonyms=PSARL; ORFNames=PRO2207; OS Homo sapiens (Human). OC Eukaryota; Metazoa; Chordata; Craniata; Vertebrata; Euteleostomi; Mammalia; OC Eutheria; Euarchontoglires; Primates; Haplorrhini; Catarrhini; Hominidae; OC Homo. OX NCBI_TaxID=9606; RN [1] RP NUCLEOTIDE SEQUENCE [MRNA] (ISOFORM 1), VARIANT LEU-262, AND INTERACTION RP WITH PSEN1 AND PSEN2. RX PubMed=12214059; DOI=10.3233/jad-2001-3203; RA Pellegrini L., Passer B.J., Canelles M., Lefterov I., Ganjei J.K., RA Fowlkes B.J., Koonin E.V., D'Adamio L.; RT "PAMP and PARL, two novel putative metalloproteases interacting with the RT COOH-terminus of presenilin-1 and -2."; RL J. Alzheimers Dis. 3:181-190(2001). RN [2] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] (ISOFORMS 1 AND 2). RC TISSUE=Lung; RX PubMed=15489334; DOI=10.1101/gr.2596504; RG The MGC Project Team; RT "The status, quality, and expansion of the NIH full-length cDNA project: RT the Mammalian Gene Collection (MGC)."; RL Genome Res. 14:2121-2127(2004). RN [3] RP NUCLEOTIDE SEQUENCE [LARGE SCALE MRNA] OF 192-379 (ISOFORM 1), AND VARIANT RP LEU-262. RC TISSUE=Fetal liver; RA Zhang C., Yu Y., Zhang S., Wei H., Zhou G., Ouyang S., Luo L., Bi J., RA Liu M., He F.; RT "Functional prediction of the coding sequences of 121 new genes deduced by RT analysis of cDNA clones from human fetal liver."; RL Submitted (DEC-1998) to the EMBL/GenBank/DDBJ databases. RN [4] RP PROTEIN SEQUENCE OF 53-61 AND 78-85, FUNCTION IN BETA CLEAVAGE, AND RP MUTAGENESIS OF ARG-76; SER-77; ALA-78 AND LEU-79. RX PubMed=14732705; DOI=10.1074/jbc.m313756200; RA Sik A., Passer B.J., Koonin E.V., Pellegrini L.; RT "Self-regulated cleavage of the mitochondrial intramembrane-cleaving RT protease PARL yields Pbeta, a nuclear-targeted peptide."; RL J. Biol. Chem. 279:15323-15329(2004). RN [5] RP FUNCTION, PHOSPHORYLATION AT SER-65; THR-69 AND SER-70 OF P-BETA, RP MUTAGENESIS OF SER-65; THR-69 AND SER-70, SUBCELLULAR LOCATION, TOPOLOGY, RP AND BETA-CLEAVAGE. RX PubMed=17116872; DOI=10.1073/pnas.0604983103; RA Jeyaraju D.V., Xu L., Letellier M.-C., Bandaru S., Zunino R., Berg E.A., RA McBride H.M., Pellegrini L.; RT "Phosphorylation and cleavage of presenilin-associated rhomboid-like RT protein (PARL) promotes changes in mitochondrial morphology."; RL Proc. Natl. Acad. Sci. U.S.A. 103:18562-18567(2006). RN [6] RP FUNCTION, CATALYTIC ACTIVITY, AND SUBCELLULAR LOCATION. RX PubMed=22354088; DOI=10.1038/embor.2012.14; RA Greene A.W., Grenier K., Aguileta M.A., Muise S., Farazifard R., RA Haque M.E., McBride H.M., Park D.S., Fon E.A.; RT "Mitochondrial processing peptidase regulates PINK1 processing, import and RT Parkin recruitment."; RL EMBO Rep. 13:378-385(2012). RN [7] RP FUNCTION, AND MUTAGENESIS OF SER-277 AND HIS-335. RX PubMed=22915595; DOI=10.1074/jbc.m112.357509; RA Sekine S., Kanamaru Y., Koike M., Nishihara A., Okada M., Kinoshita H., RA Kamiyama M., Maruyama J., Uchiyama Y., Ishihara N., Takeda K., Ichijo H.; RT "Rhomboid protease PARL mediates the mitochondrial membrane potential loss- RT induced cleavage of PGAM5."; RL J. Biol. Chem. 287:34635-34645(2012). RN [8] RP FUNCTION, AND MUTAGENESIS OF SER-277. RX PubMed=28288130; DOI=10.1038/ncb3488; RA Saita S., Nolte H., Fiedler K.U., Kashkar H., Venne A.S., Zahedi R.P., RA Krueger M., Langer T.; RT "PARL mediates Smac proteolytic maturation in mitochondria to promote RT apoptosis."; RL Nat. Cell Biol. 19:318-328(2017). RN [9] RP FUNCTION. RX PubMed=32573439; DOI=10.7554/elife.55279; RA Cupo R.R., Shorter J.; RT "Skd3 (human ClpB) is a potent mitochondrial protein disaggregase that is RT inactivated by 3-methylglutaconic aciduria-linked mutations."; RL Elife 9:0-0(2020). CC -!- FUNCTION: Required for the control of apoptosis during postnatal CC growth. Essential for proteolytic processing of an antiapoptotic form CC of OPA1 which prevents the release of mitochondrial cytochrome c in CC response to intrinsic apoptotic signals (By similarity). Required for CC the maturation of PINK1 into its 52kDa mature form after its cleavage CC by mitochondrial-processing peptidase (MPP) (PubMed:22354088). Promotes CC cleavage of serine/threonine-protein phosphatase PGAM5 in damaged CC mitochondria in response to loss of mitochondrial membrane potential CC (PubMed:22915595). Mediates differential cleavage of PINK1 and PGAM5 CC depending on the health status of mitochondria, disassociating from CC PINK1 and associating with PGAM5 in response to mitochondrial membrane CC potential loss (PubMed:22915595). Required for processing of CLPB into CC a form with higher protein disaggregase activity by removing an CC autoinhibitory N-terminal peptide (PubMed:28288130, PubMed:32573439). CC Promotes processing of DIABLO/SMAC in the mitochondrion which is CC required for DIABLO apoptotic activity (PubMed:28288130). Also required CC for cleavage of STARD7 and TTC19 (PubMed:28288130). Promotes changes in CC mitochondria morphology regulated by phosphorylation of P-beta domain CC (PubMed:14732705, PubMed:17116872). {ECO:0000250|UniProtKB:Q5XJY4, CC ECO:0000269|PubMed:14732705, ECO:0000269|PubMed:17116872, CC ECO:0000269|PubMed:22354088, ECO:0000269|PubMed:22915595, CC ECO:0000269|PubMed:28288130, ECO:0000269|PubMed:32573439}. CC -!- CATALYTIC ACTIVITY: CC Reaction=Cleaves type-1 transmembrane domains using a catalytic dyad CC composed of serine and histidine that are contributed by different CC transmembrane domains.; EC=3.4.21.105; CC Evidence={ECO:0000269|PubMed:22354088}; CC -!- SUBUNIT: Interacts with PSEN1 and PSEN2. Binds OPA1. CC {ECO:0000269|PubMed:12214059}. CC -!- SUBCELLULAR LOCATION: Mitochondrion inner membrane CC {ECO:0000269|PubMed:17116872, ECO:0000269|PubMed:22354088}; Multi-pass CC membrane protein {ECO:0000269|PubMed:17116872}. CC -!- SUBCELLULAR LOCATION: [P-beta]: Nucleus {ECO:0000269|PubMed:17116872}. CC Note=Translocated into the nucleus by an unknown mechanism CC (PubMed:17116872). {ECO:0000269|PubMed:17116872}. CC -!- ALTERNATIVE PRODUCTS: CC Event=Alternative splicing; Named isoforms=2; CC Name=1; CC IsoId=Q9H300-1; Sequence=Displayed; CC Name=2; CC IsoId=Q9H300-2; Sequence=VSP_013310; CC -!- PTM: P-beta is proteolytically processed (beta-cleavage) in a PARL- CC dependent manner. The cleavage is inhibited when residues Ser-65, Thr- CC 69 and Ser-70 are all phosphorylated. {ECO:0000269|PubMed:17116872}. CC -!- SIMILARITY: Belongs to the peptidase S54 family. {ECO:0000305}. CC --------------------------------------------------------------------------- CC Copyrighted by the UniProt Consortium, see https://www.uniprot.org/terms CC Distributed under the Creative Commons Attribution (CC BY 4.0) License CC --------------------------------------------------------------------------- DR EMBL; AF197937; AAG28519.1; -; mRNA. DR EMBL; BC003653; AAH03653.1; -; mRNA. DR EMBL; BC014058; AAH14058.1; -; mRNA. DR EMBL; AF116692; AAF71112.1; -; mRNA. DR CCDS; CCDS3248.1; -. [Q9H300-1] DR CCDS; CCDS33897.1; -. [Q9H300-2] DR RefSeq; NP_001032728.1; NM_001037639.2. [Q9H300-2] DR RefSeq; NP_061092.3; NM_018622.6. [Q9H300-1] DR AlphaFoldDB; Q9H300; -. DR SMR; Q9H300; -. DR BioGRID; 120678; 222. DR IntAct; Q9H300; 181. DR MINT; Q9H300; -. DR STRING; 9606.ENSP00000325421; -. DR BindingDB; Q9H300; -. DR ChEMBL; CHEMBL4879516; -. DR MEROPS; S54.009; -. DR TCDB; 9.B.104.1.6; the rhomboid protease (rhomboid) family. DR iPTMnet; Q9H300; -. DR PhosphoSitePlus; Q9H300; -. DR SwissPalm; Q9H300; -. DR BioMuta; PARL; -. DR DMDM; 143811433; -. DR EPD; Q9H300; -. DR jPOST; Q9H300; -. DR MassIVE; Q9H300; -. DR MaxQB; Q9H300; -. DR PaxDb; 9606-ENSP00000325421; -. DR PeptideAtlas; Q9H300; -. DR ProteomicsDB; 80637; -. [Q9H300-1] DR ProteomicsDB; 80638; -. [Q9H300-2] DR Pumba; Q9H300; -. DR Antibodypedia; 18935; 184 antibodies from 31 providers. DR DNASU; 55486; -. DR Ensembl; ENST00000311101.9; ENSP00000310676.5; ENSG00000175193.14. [Q9H300-2] DR Ensembl; ENST00000317096.9; ENSP00000325421.5; ENSG00000175193.14. [Q9H300-1] DR GeneID; 55486; -. DR KEGG; hsa:55486; -. DR MANE-Select; ENST00000317096.9; ENSP00000325421.5; NM_018622.7; NP_061092.3. DR UCSC; uc003fmd.4; human. [Q9H300-1] DR AGR; HGNC:18253; -. DR CTD; 55486; -. DR DisGeNET; 55486; -. DR GeneCards; PARL; -. DR HGNC; HGNC:18253; PARL. DR HPA; ENSG00000175193; Low tissue specificity. DR MIM; 607858; gene. DR neXtProt; NX_Q9H300; -. DR OpenTargets; ENSG00000175193; -. DR PharmGKB; PA134939789; -. DR VEuPathDB; HostDB:ENSG00000175193; -. DR eggNOG; KOG2980; Eukaryota. DR GeneTree; ENSGT00390000013063; -. DR HOGENOM; CLU_034022_0_1_1; -. DR InParanoid; Q9H300; -. DR OMA; WHEMRTR; -. DR OrthoDB; 2910971at2759; -. DR PhylomeDB; Q9H300; -. DR TreeFam; TF313603; -. DR BRENDA; 3.4.21.105; 2681. DR PathwayCommons; Q9H300; -. DR Reactome; R-HSA-8949664; Processing of SMDT1. DR SignaLink; Q9H300; -. DR SIGNOR; Q9H300; -. DR BioGRID-ORCS; 55486; 131 hits in 1160 CRISPR screens. DR ChiTaRS; PARL; human. DR GeneWiki; PARL; -. DR GenomeRNAi; 55486; -. DR Pharos; Q9H300; Tchem. DR PRO; PR:Q9H300; -. DR Proteomes; UP000005640; Chromosome 3. DR RNAct; Q9H300; Protein. DR Bgee; ENSG00000175193; Expressed in monocyte and 100 other cell types or tissues. DR ExpressionAtlas; Q9H300; baseline and differential. DR GO; GO:0005743; C:mitochondrial inner membrane; TAS:ParkinsonsUK-UCL. DR GO; GO:0005739; C:mitochondrion; IDA:UniProtKB. DR GO; GO:0005634; C:nucleus; IEA:UniProtKB-SubCell. DR GO; GO:0004175; F:endopeptidase activity; IDA:UniProtKB. DR GO; GO:0004252; F:serine-type endopeptidase activity; IMP:UniProtKB. DR GO; GO:0033619; P:membrane protein proteolysis; IDA:UniProtKB. DR GO; GO:0008053; P:mitochondrial fusion; IEA:Ensembl. DR GO; GO:2001243; P:negative regulation of intrinsic apoptotic signaling pathway; IEA:Ensembl. DR GO; GO:0090201; P:negative regulation of release of cytochrome c from mitochondria; IEA:Ensembl. DR GO; GO:0016485; P:protein processing; IMP:UniProtKB. DR GO; GO:0006508; P:proteolysis; IMP:ParkinsonsUK-UCL. DR GO; GO:0010821; P:regulation of mitochondrion organization; IMP:ParkinsonsUK-UCL. DR GO; GO:1901524; P:regulation of mitophagy; ISS:ParkinsonsUK-UCL. DR GO; GO:1903214; P:regulation of protein targeting to mitochondrion; IGI:ParkinsonsUK-UCL. DR GO; GO:0030162; P:regulation of proteolysis; IGI:ParkinsonsUK-UCL. DR GO; GO:2000377; P:regulation of reactive oxygen species metabolic process; IMP:ParkinsonsUK-UCL. DR GO; GO:0006465; P:signal peptide processing; IBA:GO_Central. DR Gene3D; 1.20.1540.10; Rhomboid-like; 1. DR InterPro; IPR022764; Peptidase_S54_rhomboid_dom. DR InterPro; IPR035952; Rhomboid-like_sf. DR PANTHER; PTHR43731:SF31; PRESENILINS-ASSOCIATED RHOMBOID-LIKE PROTEIN, MITOCHONDRIAL; 1. DR PANTHER; PTHR43731; RHOMBOID PROTEASE; 1. DR Pfam; PF01694; Rhomboid; 1. DR SUPFAM; SSF144091; Rhomboid-like; 1. DR Genevisible; Q9H300; HS. PE 1: Evidence at protein level; KW Alternative splicing; Direct protein sequencing; Hydrolase; Membrane; KW Mitochondrion; Mitochondrion inner membrane; Nucleus; Phosphoprotein; KW Protease; Reference proteome; Serine protease; Transit peptide; KW Transmembrane; Transmembrane helix. FT TRANSIT 1..52 FT /note="Mitochondrion" FT /evidence="ECO:0000269|PubMed:14732705" FT CHAIN 53..379 FT /note="Presenilin-associated rhomboid-like protein, FT mitochondrial" FT /id="PRO_0000027386" FT PEPTIDE 53..77 FT /note="P-beta" FT /evidence="ECO:0000269|PubMed:14732705" FT /id="PRO_0000027387" FT TOPO_DOM 53..101 FT /note="Mitochondrial matrix" FT /evidence="ECO:0000255" FT TRANSMEM 102..121 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 122..167 FT /note="Mitochondrial intermembrane" FT /evidence="ECO:0000255" FT TRANSMEM 168..187 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 188..207 FT /note="Mitochondrial matrix" FT /evidence="ECO:0000255" FT TRANSMEM 208..230 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 231..244 FT /note="Mitochondrial intermembrane" FT /evidence="ECO:0000255" FT TRANSMEM 245..262 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 263..272 FT /note="Mitochondrial matrix" FT /evidence="ECO:0000255" FT TRANSMEM 273..289 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 290..295 FT /note="Mitochondrial intermembrane" FT /evidence="ECO:0000255" FT TRANSMEM 296..318 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 319..332 FT /note="Mitochondrial matrix" FT /evidence="ECO:0000255" FT TRANSMEM 333..354 FT /note="Helical" FT /evidence="ECO:0000255" FT TOPO_DOM 355..379 FT /note="Mitochondrial intermembrane" FT /evidence="ECO:0000255" FT ACT_SITE 277 FT /note="Nucleophile" FT /evidence="ECO:0000250" FT ACT_SITE 335 FT /evidence="ECO:0000250" FT MOD_RES 65 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:17116872" FT MOD_RES 69 FT /note="Phosphothreonine" FT /evidence="ECO:0000269|PubMed:17116872" FT MOD_RES 70 FT /note="Phosphoserine" FT /evidence="ECO:0000269|PubMed:17116872" FT VAR_SEQ 203..253 FT /note="KVLCSPMLLSTFSHFSLFHMAANMYVLWSFSSSIVNILGQEQFMAVYLSAG FT -> S (in isoform 2)" FT /evidence="ECO:0000303|PubMed:15489334" FT /id="VSP_013310" FT VARIANT 137 FT /note="A -> G (in dbSNP:rs4912470)" FT /id="VAR_029801" FT VARIANT 262 FT /note="V -> L (in dbSNP:rs3732581)" FT /evidence="ECO:0000269|PubMed:12214059, ECO:0000269|Ref.3" FT /id="VAR_021578" FT MUTAGEN 65 FT /note="S->D: Strongly reduces the beta cleavage; when FT associated with D-69 and D-70." FT /evidence="ECO:0000269|PubMed:17116872" FT MUTAGEN 69 FT /note="T->D: Strongly reduces the beta cleavage; when FT associated with D-65 and D-70." FT /evidence="ECO:0000269|PubMed:17116872" FT MUTAGEN 70 FT /note="S->D: Strongly reduces the beta cleavage; when FT associated with D-65 and D-69." FT /evidence="ECO:0000269|PubMed:17116872" FT MUTAGEN 76 FT /note="R->E: Abolishes the beta cleavage." FT /evidence="ECO:0000269|PubMed:14732705" FT MUTAGEN 76 FT /note="R->G: Abolishes the beta cleavage." FT /evidence="ECO:0000269|PubMed:14732705" FT MUTAGEN 77 FT /note="S->E: Abolishes the beta cleavage." FT /evidence="ECO:0000269|PubMed:14732705" FT MUTAGEN 78 FT /note="A->E: Abolishes the beta cleavage." FT /evidence="ECO:0000269|PubMed:14732705" FT MUTAGEN 79 FT /note="L->E: Abolishes the beta cleavage." FT /evidence="ECO:0000269|PubMed:14732705" FT MUTAGEN 277 FT /note="S->A: Loss of cleavage of CLPB, DIABLO, STARD7 and FT TTC19." FT /evidence="ECO:0000269|PubMed:28288130" FT MUTAGEN 277 FT /note="S->G: Loss of PGAM5 cleavage." FT /evidence="ECO:0000269|PubMed:22915595" FT MUTAGEN 335 FT /note="H->A: Loss of PGAM5 cleavage." FT /evidence="ECO:0000269|PubMed:22915595" SQ SEQUENCE 379 AA; 42190 MW; 2B07EF04C7130B0B CRC64; MAWRGWAQRG WGCGQAWGAS VGGRSCEELT AVLTPPQLLG RRFNFFIQQK CGFRKAPRKV EPRRSDPGTS GEAYKRSALI PPVEETVFYP SPYPIRSLIK PLFFTVGFTG CAFGSAAIWQ YESLKSRVQS YFDGIKADWL DSIRPQKEGD FRKEINKWWN NLSDGQRTVT GIIAANVLVF CLWRVPSLQR TMIRYFTSNP ASKVLCSPML LSTFSHFSLF HMAANMYVLW SFSSSIVNIL GQEQFMAVYL SAGVISNFVS YVGKVATGRY GPSLGASGAI MTVLAAVCTK IPEGRLAIIF LPMFTFTAGN ALKAIIAMDT AGMILGWKFF DHAAHLGGAL FGIWYVTYGH ELIWKNREPL VKIWHEIRTN GPKKGGGSK //